Across TCGA pan-cancer cohorts, FBLIM1P1 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of FBLIM1P1’s most consistent transcriptional readouts.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where FBLIM1P1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types FBLIM1P1 is over-expressed in tumor.

UCEC, HNSC, and LUAD are the cancer types where FBLIM1P1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in FBLIM1P1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
UCEC	All	III,IV	+0.063	.024	6	view →
HNSC	Male	III,IV	+0.024	.019	3	view →
LUAD	All	II,III,IV	+0.018	.023	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: FBLIM1P1 RNA expression & survival · all FBLIM1P1 data types